Literature DB >> 18173688

Desmopressin: an historical introduction.

P M Mannucci1.   

Abstract

This review summarizes the steps that led to the development of desmopressin as a hemostatic agent. This drug has broadened the panel of pharmacological agents that can be used to treat or prevent bleeding in patients with mild hemophilia and von Willebrand disease.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18173688     DOI： 10.1111/j.1365-2516.2007.01609.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


  4 in total

Review 1.  Desmopressin for minimising perioperative allogeneic blood transfusion.

Authors:  P A Carless; D A Henry; A J Moxey; D O'Connell; B McClelland; K M Henderson; K Sly; A Laupacis; D Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2004

2.  Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

3.  New treatments in hemophilia: insights for the clinician.

Authors:  Karin Knobe; Erik Berntorp
Journal:  Ther Adv Hematol       Date:  2012-06

Review 4.  Novel therapies and current clinical progress in hemophilia A.

Authors:  Pauline Balkaransingh; Guy Young
Journal:  Ther Adv Hematol       Date:  2017-12-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.